David A. Siegel Biodesix Inc Transaction History

Two Sigma Advisers, LP

  • $42.5 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.32 - $2.12 $51,480 - $82,680
-39,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.69 - $5.81 $8,112 - $27,887
4,800 Added 14.04%
39,000 $66,000
Q4 2021

Feb 14, 2022
BUY
$4.09 - $8.67 $62,168 - $131,784
15,200 Added 80.0%
34,200 $181,000
Q3 2021

Nov 15, 2021
BUY
$6.6 - $12.78 $125,400 - $242,820
19,000 New
19,000 $156,000

Others Institutions Holding BDSX

# of Institutions
45
Shares Held
16.2M
Call Options Held
0
Put Options Held
0
View Full List

About BIODESIX INC

BDSX Quotes by TradingView
  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $63.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email